Vanda Pharmaceuticals (VNDA) Assets Average (2016 - 2025)
Historic Assets Average for Vanda Pharmaceuticals (VNDA) over the last 16 years, with Q3 2025 value amounting to $612.9 million.
- Vanda Pharmaceuticals' Assets Average fell 544.55% to $612.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $612.9 million, marking a year-over-year decrease of 544.55%. This contributed to the annual value of $652.3 million for FY2024, which is 171.18% up from last year.
- Per Vanda Pharmaceuticals' latest filing, its Assets Average stood at $612.9 million for Q3 2025, which was down 544.55% from $628.3 million recorded in Q2 2025.
- In the past 5 years, Vanda Pharmaceuticals' Assets Average ranged from a high of $652.0 million in Q2 2024 and a low of $538.3 million during Q1 2021
- For the 5-year period, Vanda Pharmaceuticals' Assets Average averaged around $618.9 million, with its median value being $628.3 million (2025).
- In the last 5 years, Vanda Pharmaceuticals' Assets Average surged by 1221.24% in 2021 and then plummeted by 544.55% in 2025.
- Vanda Pharmaceuticals' Assets Average (Quarter) stood at $586.8 million in 2021, then grew by 7.03% to $628.0 million in 2022, then rose by 2.71% to $645.0 million in 2023, then increased by 0.87% to $650.7 million in 2024, then decreased by 5.8% to $612.9 million in 2025.
- Its Assets Average was $612.9 million in Q3 2025, compared to $628.3 million in Q2 2025 and $644.1 million in Q1 2025.